PURPOSE: Caspase-8 is a key regulator of apoptosis. Its cancer cell antigen induced cell death activity is strongly impacted by the insertion/deletion promoter polymorphism CASP8 -652 6N ins/del (rs3834129). We studied the association of this polymorphism with renal cell carcinoma risk and pathology. MATERIALS AND METHODS: In this hospital based case-control study 500 Austrian patients were genotyped, including 250 with renal cell carcinoma, and 250 age and gender matched healthy controls. Polymerase chain reaction amplified genomic DNA was evaluated by restriction fragment length polymorphism analysis and automatic sequencing. We assessed associations with renal cell carcinoma risk and pathological factors, and performed a meta-analysis of the literature. RESULTS: The CASP8 -652 6N ins/del polymorphism was significantly linked to renal cell carcinoma (chi-square for trend = 9.50, p = 0.002). Compared with ins/ins, del/del was associated with a 57% decreased risk of the disease (OR 0.43, 95% CI 0.26-0.73, p = 0.002). Furthermore, del/del was associated with a lower risk of distant metastases (p <0.05) but not with T stage, N stage or grade. On meta-analysis the CASP8 -652 6N ins/del polymorphism was associated with renal cell carcinoma risk (p <0.001). CONCLUSIONS: The del/del genotype of the CASP8 -652 6N ins/del promoter polymorphism decreases the overall risk of renal cell carcinoma. It may be associated with a decreased risk of metastasis. Larger studies are warranted to validate our findings.
PURPOSE:Caspase-8 is a key regulator of apoptosis. Its cancer cell antigen induced cell death activity is strongly impacted by the insertion/deletion promoter polymorphism CASP8 -652 6N ins/del (rs3834129). We studied the association of this polymorphism with renal cell carcinoma risk and pathology. MATERIALS AND METHODS: In this hospital based case-control study 500 Austrian patients were genotyped, including 250 with renal cell carcinoma, and 250 age and gender matched healthy controls. Polymerase chain reaction amplified genomic DNA was evaluated by restriction fragment length polymorphism analysis and automatic sequencing. We assessed associations with renal cell carcinoma risk and pathological factors, and performed a meta-analysis of the literature. RESULTS: The CASP8 -652 6N ins/del polymorphism was significantly linked to renal cell carcinoma (chi-square for trend = 9.50, p = 0.002). Compared with ins/ins, del/del was associated with a 57% decreased risk of the disease (OR 0.43, 95% CI 0.26-0.73, p = 0.002). Furthermore, del/del was associated with a lower risk of distant metastases (p <0.05) but not with T stage, N stage or grade. On meta-analysis the CASP8 -652 6N ins/del polymorphism was associated with renal cell carcinoma risk (p <0.001). CONCLUSIONS: The del/del genotype of the CASP8 -652 6N ins/del promoter polymorphism decreases the overall risk of renal cell carcinoma. It may be associated with a decreased risk of metastasis. Larger studies are warranted to validate our findings.
Authors: Ewelina Pośpiech; Janusz Ligęza; Wacław Wilk; Aniela Gołas; Janusz Jaszczyński; Andrzej Stelmach; Janusz Ryś; Aleksandra Blecharczyk; Anna Wojas-Pelc; Jolanta Jura; Wojciech Branicki Journal: Biomed Res Int Date: 2015-04-06 Impact factor: 3.411
Authors: Giovanna C Cavalcante; Marcos At Amador; André M Ribeiro Dos Santos; Darlen C Carvalho; Roberta B Andrade; Esdras Eb Pereira; Marianne R Fernandes; Danielle F Costa; Ney Pc Santos; Paulo P Assumpção; Ândrea Ribeiro Dos Santos; Sidney Santos Journal: World J Gastroenterol Date: 2017-12-28 Impact factor: 5.742
Authors: Sofia Khan; Dario Greco; Kyriaki Michailidou; Roger L Milne; Taru A Muranen; Tuomas Heikkinen; Kirsimari Aaltonen; Joe Dennis; Manjeet K Bolla; Jianjun Liu; Per Hall; Astrid Irwanto; Keith Humphreys; Jingmei Li; Kamila Czene; Jenny Chang-Claude; Rebecca Hein; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Olivia Fletcher; Julian Peto; Isabel dos Santos Silva; Nichola Johnson; Lorna Gibson; Zoe Aitken; John L Hopper; Helen Tsimiklis; Minh Bui; Enes Makalic; Daniel F Schmidt; Melissa C Southey; Carmel Apicella; Jennifer Stone; Quinten Waisfisz; Hanne Meijers-Heijboer; Muriel A Adank; Rob B van der Luijt; Alfons Meindl; Rita K Schmutzler; Bertram Müller-Myhsok; Peter Lichtner; Clare Turnbull; Nazneen Rahman; Stephen J Chanock; David J Hunter; Angela Cox; Simon S Cross; Malcolm W R Reed; Marjanka K Schmidt; Annegien Broeks; Laura J Van't Veer; Frans B Hogervorst; Peter A Fasching; Michael G Schrauder; Arif B Ekici; Matthias W Beckmann; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Javier Benitez; Pilar M Zamora; Jose I A Perez; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Paul D P Pharoah; Alison M Dunning; Mitul Shah; Robert Luben; Judith Brown; Fergus J Couch; Xianshu Wang; Celine Vachon; Janet E Olson; Diether Lambrechts; Matthieu Moisse; Robert Paridaens; Marie-Rose Christiaens; Pascal Guénel; Thérèse Truong; Pierre Laurent-Puig; Claire Mulot; Frederick Marme; Barbara Burwinkel; Andreas Schneeweiss; Christof Sohn; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Irene L Andrulis; Julia A Knight; Sandrine Tchatchou; Anna Marie Mulligan; Thilo Dörk; Natalia V Bogdanova; Natalia N Antonenkova; Hoda Anton-Culver; Hatef Darabi; Mikael Eriksson; Montserrat Garcia-Closas; Jonine Figueroa; Jolanta Lissowska; Louise Brinton; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Christi J van Asperen; Vessela N Kristensen; Susan Slager; Amanda E Toland; Christine B Ambrosone; Drakoulis Yannoukakos; Annika Lindblom; Sara Margolin; Paolo Radice; Paolo Peterlongo; Monica Barile; Paolo Mariani; Maartje J Hooning; John W M Martens; J Margriet Collée; Agnes Jager; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Graham G Giles; Catriona McLean; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Anthony Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Jacques Simard; Mark S Goldberg; France Labrèche; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Arto Mannermaa; Ute Hamann; Georgia Chenevix-Trench; Carl Blomqvist; Kristiina Aittomäki; Douglas F Easton; Heli Nevanlinna Journal: PLoS One Date: 2014-11-12 Impact factor: 3.240
Authors: Sven Diederichs; Lorenz Bartsch; Julia C Berkmann; Karin Fröse; Jana Heitmann; Caroline Hoppe; Deetje Iggena; Danny Jazmati; Philipp Karschnia; Miriam Linsenmeier; Thomas Maulhardt; Lino Möhrmann; Johannes Morstein; Stella V Paffenholz; Paula Röpenack; Timo Rückert; Ludger Sandig; Maximilian Schell; Anna Steinmann; Gjendine Voss; Jacqueline Wasmuth; Maria E Weinberger; Ramona Wullenkord Journal: EMBO Mol Med Date: 2016-05-02 Impact factor: 12.137